Free Trial

Veeco Instruments (VECO) Financials

Veeco Instruments logo
$58.64 -0.87 (-1.46%)
Closing price 05/15/2026 04:00 PM Eastern
Extended Trading
$58.00 -0.64 (-1.09%)
As of 05/15/2026 07:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Veeco Instruments

Annual Income Statements for Veeco Instruments

This table shows Veeco Instruments' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-32 -122 -51 -407 -79 -8.39 26 167 -30 74 35
Consolidated Net Income / (Loss)
-32 -122 -51 -407 -79 -8.39 26 167 -30 74 35
Net Income / (Loss) Continuing Operations
-32 -122 -51 -407 -79 -8.39 26 167 -30 74 35
Total Pre-Tax Income
-23 -119 -89 -434 -78 -8.46 26 51 -28 69 39
Total Operating Income
-23 -120 -72 -416 -40 23 57 60 70 67 36
Total Gross Profit
177 133 176 194 158 194 242 263 285 304 265
Total Revenue
477 332 476 542 419 454 583 646 666 717 664
Operating Revenue
477 332 476 542 419 454 583 646 666 717 664
Total Cost of Revenue
300 199 299 348 261 260 341 383 381 413 399
Operating Cost of Revenue
300 199 299 348 261 260 341 383 381 413 399
Total Operating Expenses
200 253 248 609 198 172 186 203 215 237 230
Selling, General & Admin Expense
90 78 100 92 80 76 85 89 93 100 99
Research & Development Expense
79 81 82 98 91 79 89 104 113 125 120
Amortization Expense
28 19 35 32 17 15 12 10 8.48 6.98 3.14
Other Operating Expenses / (Income)
-0.70 0.22 -0.39 0.37 -0.04 -0.22 0.07 0.32 1.03 -22 -0.89
Impairment Charge
0.13 70 1.14 375 4.02 0.28 - 0.00 0.00 28 0.00
Restructuring Charge
4.68 5.64 30 12 6.40 1.10 - - 0.00 0.00 8.91
Total Other Income / (Expense), net
0.59 0.96 -17 -18 -38 -31 -31 -9.31 -98 1.85 3.68
Interest Expense
0.46 0.22 19 22 22 25 28 12 12 11 9.14
Interest & Investment Income
1.05 1.18 2.34 3.19 4.68 1.55 2.34 2.20 11 13 13
Other Income / (Expense), net
- - - 0.00 -21 -7.84 -5.01 0.00 -97 0.00 -0.65
Income Tax Expense
9.33 2.82 -38 -27 0.78 -0.07 -0.36 -116 2.03 -4.88 4.00
Basic Earnings per Share
($0.80) ($3.10) ($1.16) ($8.63) ($1.66) ($0.17) $0.53 $3.35 ($0.56) $1.31 $0.60
Weighted Average Basic Shares Outstanding
39.74M 39.34M 44.17M 47.15M 47.48M 48.36M 49.07M 49.91M 53.77M 56.43M 59.30M
Diluted Earnings per Share
($0.80) ($3.10) ($1.16) ($8.63) ($1.66) ($0.17) $0.49 $2.71 ($0.56) $1.23 $0.59
Weighted Average Diluted Shares Outstanding
39.74M 39.34M 44.17M 47.15M 47.48M 48.36M 53.64M 65.61M 53.77M 61.60M 60.59M
Weighted Average Basic & Diluted Shares Outstanding
40M 39.30M 44.30M 47.20M 49.00M 49.72M 50.65M 51.66M 56.37M 57.94M 60.39M

Quarterly Income Statements for Veeco Instruments

This table shows Veeco Instruments' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
25 22 22 15 22 15 12 12 11 1.11 -0.32
Consolidated Net Income / (Loss)
25 22 22 15 22 15 12 12 11 1.11 -0.32
Net Income / (Loss) Continuing Operations
25 22 22 15 22 15 12 12 11 1.11 -0.32
Total Pre-Tax Income
23 24 23 17 25 4.36 15 13 12 -0.09 -1.48
Total Operating Income
22 24 22 17 24 3.88 14 12 11 -1.37 -2.66
Total Gross Profit
77 79 75 75 79 74 68 69 68 61 56
Total Revenue
177 174 174 176 185 182 167 166 166 165 158
Operating Revenue
177 174 174 176 185 182 167 166 166 165 158
Total Cost of Revenue
100 95 99 100 106 108 99 97 98 105 103
Operating Cost of Revenue
100 95 99 100 106 108 99 97 98 105 103
Total Operating Expenses
55 54 53 59 55 70 54 56 57 62 58
Selling, General & Admin Expense
23 23 25 25 25 25 25 24 27 23 26
Research & Development Expense
29 29 30 32 32 31 29 32 29 31 30
Amortization Expense
2.12 2.12 1.89 1.83 1.69 1.58 0.82 0.82 0.77 0.72 0.71
Other Operating Expenses / (Income)
0.86 -0.24 -2.86 0.55 -4.32 -16 -0.04 0.05 0.13 -1.02 -0.12
Restructuring Charge
- - - - - - 0.00 - - - 2.01
Total Other Income / (Expense), net
0.25 - 0.71 0.35 0.32 0.48 0.84 0.25 1.32 1.27 1.18
Interest Expense
2.78 3.07 2.62 2.77 2.88 2.78 2.51 2.29 2.16 2.18 2.10
Interest & Investment Income
3.02 3.07 3.32 3.12 3.20 3.26 3.34 3.20 3.49 3.45 3.28
Income Tax Expense
-2.06 2.55 0.90 2.13 2.71 -11 3.04 0.89 1.28 -1.21 -1.16
Basic Earnings per Share
$0.44 $0.44 $0.39 $0.27 $0.39 $0.26 $0.21 $0.20 $0.18 $0.01 ($0.01)
Weighted Average Basic Shares Outstanding
55.35M 53.77M 55.97M 56.28M 56.41M 56.43M 57.75M 59.08M 60.08M 59.30M 60.41M
Diluted Earnings per Share
$0.42 $0.46 $0.37 $0.25 $0.36 $0.25 $0.20 $0.20 $0.17 $0.02 ($0.01)
Weighted Average Diluted Shares Outstanding
59.64M 53.77M 60.76M 62.54M 62.65M 61.60M 60.23M 60.24M 60.95M 60.59M 60.41M
Weighted Average Basic & Diluted Shares Outstanding
56.34M 56.37M 56.64M 56.78M 56.78M 57.94M 58.29M 60.16M 60.16M 60.39M 61.03M

Annual Cash Flow Statements for Veeco Instruments

This table details how cash moves in and out of Veeco Instruments' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
-1.58 8.23 3.10 -67 -83 0.33 -9.81 35 3.65 -13 18
Net Cash From Operating Activities
16 -24 35 -38 -7.42 43 68 108 62 64 69
Net Cash From Continuing Operating Activities
16 -24 35 -38 -7.42 43 68 108 62 64 69
Net Income / (Loss) Continuing Operations
-32 -122 -51 -407 -79 -8.39 26 167 -30 74 35
Consolidated Net Income / (Loss)
-32 -122 -51 -407 -79 -8.39 26 167 -30 74 35
Depreciation Expense
40 33 50 50 34 31 26 26 25 25 20
Amortization Expense
- - 10 12 13 14 14 0.96 1.12 1.26 1.12
Non-Cash Adjustments To Reconcile Net Income
17 76 36 413 46 -9.40 -11 74 130 4.82 35
Changes in Operating Assets and Liabilities, net
-8.98 -11 -10 -105 -22 16 12 -159 -64 -41 -22
Net Cash From Investing Activities
-7.08 47 -358 -18 -76 -72 45 -69 -53 -65 -41
Net Cash From Continuing Investing Activities
-7.08 47 -358 -18 -76 -72 45 -69 -53 -65 -41
Purchase of Property, Plant & Equipment
-14 -11 -24 -13 -11 -6.80 -41 -25 -28 -18 -16
Acquisitions
-0.07 - -402 -2.66 - - 0.00 0.00 -30 0.00 0.00
Purchase of Investments
-86 -103 -283 -93 -193 -248 -247 -104 -178 -203 -224
Sale of Property, Plant & Equipment
3.07 9.51 2.28 0.00 0.65 9.50 1.73 0.00 0.00 2.03 0.00
Sale and/or Maturity of Investments
89 152 349 90 127 174 331 60 183 154 198
Net Cash From Financing Activities
-10 -15 326 -11 0.13 29 -122 -4.55 -4.68 -13 -10
Net Cash From Continuing Financing Activities
-10 -15 326 -11 0.13 29 -122 -4.55 -4.68 -13 -10
Repayment of Debt
-0.31 -0.34 -1.19 0.00 0.00 -81 -116 0.00 -219 0.00 -6.11
Issuance of Debt
- - 336 0.00 0.00 120 0.00 0.00 223 0.00 0.00
Issuance of Common Equity
2.23 1.66 2.99 3.06 3.11 2.88 3.40 3.70 4.62 5.30 4.72
Other Financing Activities, net
-3.22 -2.60 -8.74 -3.07 -2.98 -13 -8.99 -8.25 -14 -18 -9.07
Effect of Exchange Rate Changes
-0.09 - - - 0.03 0.01 -0.05 -0.05 -0.02 0.01 0.10
Cash Interest Paid
0.49 0.23 4.68 9.71 9.41 13 13 10 12 9.50 8.23
Cash Income Taxes Paid
7.09 1.67 1.94 4.80 2.93 0.33 -0.14 1.43 5.10 3.03 0.09

Quarterly Cash Flow Statements for Veeco Instruments

This table details how cash moves in and out of Veeco Instruments' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
-24 2.32 15 0.13 -11 -18 29 14 4.23 -30 16
Net Cash From Operating Activities
7.05 29 9.36 8.46 18 28 20 9.04 16 25 7.94
Net Cash From Continuing Operating Activities
7.05 29 9.36 8.46 18 28 20 9.04 16 25 7.94
Net Income / (Loss) Continuing Operations
25 22 22 15 22 15 12 12 11 1.11 -0.32
Consolidated Net Income / (Loss)
25 22 22 15 22 15 12 12 11 1.11 -0.32
Depreciation Expense
6.18 6.35 6.41 6.60 6.15 5.98 5.04 5.10 4.90 4.98 5.04
Amortization Expense
0.31 0.29 0.30 0.32 0.32 0.32 0.26 0.29 0.28 0.29 0.24
Non-Cash Adjustments To Reconcile Net Income
-23 21 -30 5.01 16 14 -13 15 3.99 28 0.36
Changes in Operating Assets and Liabilities, net
-1.15 -20 10 -18 -26 -6.68 15 -23 -4.23 -9.62 2.62
Net Cash From Investing Activities
-30 -26 21 -9.94 -30 -46 15 9.54 -12 -53 18
Net Cash From Continuing Investing Activities
-30 -26 21 -9.94 -30 -46 15 9.54 -12 -53 18
Purchase of Property, Plant & Equipment
-6.40 -11 -5.99 -2.95 -3.99 -5.18 -6.76 -3.60 -2.58 -3.27 -5.10
Purchase of Investments
-41 -67 -29 -35 -61 -78 -45 -25 -60 -93 -13
Sale and/or Maturity of Investments
18 52 53 28 35 38 66 38 51 43 36
Net Cash From Financing Activities
-1.66 -1.05 -15 1.62 0.90 -0.25 -5.28 -4.71 0.82 -1.31 -9.56
Net Cash From Continuing Financing Activities
-1.66 -1.05 -15 1.62 0.90 -0.25 -5.28 -4.71 0.82 -1.31 -9.56
Repayment of Debt
- - 0.00 - - - 0.00 -6.11 - - 0.00
Issuance of Debt
- - 0.00 - - - 0.00 - - - 0.00
Issuance of Common Equity
1.09 0.91 1.32 1.87 1.18 0.94 1.40 1.48 0.93 0.91 1.48
Other Financing Activities, net
-2.75 -1.96 -16 -0.25 -0.29 -1.19 -6.68 -0.07 -0.11 -2.22 -11
Effect of Exchange Rate Changes
-0.01 0.04 -0.04 -0.00 0.14 -0.08 0.01 0.05 0.01 0.04 0.00
Cash Interest Paid
0.67 4.49 0.62 4.06 0.80 4.02 0.71 3.91 0.15 3.47 0.14
Cash Income Taxes Paid
0.88 1.23 0.99 1.54 0.44 0.07 -1.67 1.27 0.48 0.02 0.71

Annual Balance Sheets for Veeco Instruments

This table presents Veeco Instruments' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
891 759 1,387 901 818 898 899 1,128 1,229 1,252 1,326
Total Current Assets
542 502 597 520 476 587 549 669 706 765 845
Cash & Equivalents
269 277 280 212 129 130 120 155 159 146 163
Short-Term Investments
116 67 48 48 115 190 104 147 147 199 227
Accounts Receivable
50 58 99 77 71 101 128 141 127 134 146
Inventories, net
77 77 120 156 133 146 171 207 238 247 275
Prepaid Expenses
23 16 33 22 15 19 26 18 35 39 34
Plant, Property, & Equipment, net
80 61 85 80 76 65 100 107 118 114 109
Total Noncurrent Assets
269 196 705 300 266 246 250 352 404 373 372
Goodwill
115 115 307 184 182 182 182 182 215 215 215
Intangible Assets
132 58 370 85 62 46 34 24 44 8.83 5.70
Noncurrent Deferred & Refundable Income Taxes
1.38 2.05 3.05 1.87 1.55 1.44 1.64 116 118 120 123
Other Noncurrent Operating Assets
21 21 25 29 21 16 32 30 27 29 28
Total Liabilities & Shareholders' Equity
891 759 1,387 901 818 898 899 1,128 1,229 1,252 1,326
Total Liabilities
176 164 547 463 444 490 461 550 557 481 440
Total Current Liabilities
162 144 224 160 118 147 189 258 218 192 178
Accounts Payable
30 23 50 40 21 34 44 52 42 44 55
Accrued Expenses
49 33 58 46 41 45 80 56 58 55 46
Current Deferred Revenue
76 85 112 73 55 67 63 127 118 65 74
Current Deferred & Payable Income Tax Liabilities
6.21 2.31 3.85 1.26 0.83 0.91 1.86 2.43 0.00 2.09 3.05
Total Noncurrent Liabilities
14 20 323 303 325 343 272 292 339 289 262
Long-Term Debt
1.19 0.83 276 287 300 321 229 254 275 250 226
Noncurrent Deferred & Payable Income Tax Liabilities
11 13 37 5.69 5.65 5.24 4.79 1.29 6.55 0.69 0.53
Other Noncurrent Operating Liabilities
1.54 6.40 11 9.91 20 17 38 37 57 38 36
Total Equity & Noncontrolling Interests
715 595 840 438 375 408 438 578 672 771 886
Total Preferred & Common Equity
715 595 840 438 375 408 438 578 672 771 886
Total Common Equity
715 595 840 438 375 408 438 578 672 771 886
Common Stock
768 764 1,052 1,062 1,072 1,114 1,117 1,079 1,203 1,228 1,307
Retained Earnings
-45 -169 -213 -620 -699 -707 -681 -502 -532 -458 -423
Accumulated Other Comprehensive Income / (Loss)
1.35 1.78 1.81 1.82 1.89 1.85 1.48 0.93 1.61 1.52 1.79

Quarterly Balance Sheets for Veeco Instruments

This table presents Veeco Instruments' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets
997 1,167 1,228 1,246 1,234 1,235 1,273 1,279 1,275 1,290 1,353
Total Current Assets
650 643 709 721 716 718 761 795 792 810 873
Cash & Equivalents
169 141 181 156 174 174 163 175 189 193 180
Short-Term Investments
102 112 106 130 123 131 158 178 166 176 204
Accounts Receivable
173 138 151 152 141 132 163 148 143 148 172
Inventories, net
188 226 244 252 243 245 242 254 259 263 282
Prepaid Expenses
18 26 27 30 35 36 35 39 35 30 36
Plant, Property, & Equipment, net
108 113 112 118 115 113 113 114 111 109 108
Total Noncurrent Assets
238 411 407 407 403 403 399 370 372 370 372
Goodwill
182 215 215 215 215 215 215 215 215 215 215
Intangible Assets
26 50 48 46 42 40 39 8.01 7.19 6.42 4.99
Noncurrent Deferred & Refundable Income Taxes
1.64 116 115 118 119 118 116 119 120 120 124
Other Noncurrent Operating Assets
29 30 29 28 27 30 30 29 30 29 28
Total Liabilities & Shareholders' Equity
997 1,167 1,228 1,246 1,234 1,235 1,273 1,279 1,275 1,290 1,353
Total Liabilities
556 582 616 602 546 520 526 467 419 414 469
Total Current Liabilities
260 267 282 268 234 204 215 179 155 151 207
Accounts Payable
51 62 63 63 54 47 50 58 50 44 60
Accrued Expenses
65 69 62 66 59 50 57 62 47 50 52
Current Deferred Revenue
122 133 157 139 94 81 80 57 58 57 93
Current Deferred & Payable Income Tax Liabilities
1.57 2.53 0.56 0.48 0.85 - 1.06 1.55 0.62 0.33 1.76
Total Noncurrent Liabilities
295 315 334 334 311 316 311 288 263 263 263
Long-Term Debt
254 255 274 275 249 249 249 250 225 226 226
Noncurrent Deferred & Payable Income Tax Liabilities
4.75 6.94 6.88 6.87 6.50 6.45 6.38 0.66 0.65 0.63 0.51
Other Noncurrent Operating Liabilities
36 53 52 52 56 61 55 37 37 36 36
Total Equity & Noncontrolling Interests
441 586 613 644 688 715 747 812 856 876 884
Total Preferred & Common Equity
441 586 613 644 688 715 747 812 856 876 884
Total Common Equity
441 586 613 644 688 715 747 812 856 876 884
Common Stock
1,072 1,077 1,190 1,197 1,197 1,209 1,218 1,257 1,289 1,298 1,306
Retained Earnings
-631 -493 -578 -554 -510 -495 -473 -447 -435 -424 -423
Accumulated Other Comprehensive Income / (Loss)
0.22 1.40 1.37 1.50 1.48 1.47 1.85 1.63 1.66 1.80 1.32

Annual Metrics And Ratios for Veeco Instruments

This table displays calculated financial ratios and metrics derived from Veeco Instruments' official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
21.42% -30.47% 43.41% 13.96% -22.64% 8.30% 28.43% 10.78% 3.14% 7.63% -7.39%
EBITDA Growth
130.42% -626.61% 87.06% -3,023.00% 96.19% 539.40% 54.66% -5.10% -101.23% 8,851.73% -39.83%
EBIT Growth
70.67% -417.23% 40.19% -478.15% 85.43% 124.32% 251.13% 16.63% -145.03% 346.70% -47.67%
NOPAT Growth
70.67% -417.23% 40.19% -478.15% 90.47% 157.01% 264.03% 243.35% -75.20% 46.51% -55.27%
Net Income Growth
52.23% -281.60% 57.88% -692.06% 80.66% 89.34% 410.31% 541.15% -118.19% 342.74% -51.99%
EPS Growth
52.94% -287.50% 62.58% -643.97% 80.76% 89.76% 388.24% 453.06% -120.66% 319.64% -52.03%
Operating Cash Flow Growth
-62.47% -251.02% 246.76% -207.84% 80.35% 680.11% 57.46% 60.14% -43.15% 3.47% 8.90%
Free Cash Flow Firm Growth
100.66% -1,445.79% -5,877.42% 105.56% -44.82% 36.47% -0.14% 268.31% -147.74% 125.28% 21.34%
Invested Capital Growth
-4.96% -22.80% 212.99% -41.08% -9.85% -2.10% 8.05% 24.21% 16.76% 9.48% 2.68%
Revenue Q/Q Growth
-1.45% -3.96% 10.91% -6.98% 3.51% 6.01% 2.46% 0.13% 3.11% 1.16% -2.51%
EBITDA Q/Q Growth
141.38% 2.89% 50.45% -60.03% 89.18% 17.91% 0.34% -7.38% -101.25% -18.10% -10.98%
EBIT Q/Q Growth
70.16% 4.03% -16.30% -42.54% 64.73% 188.88% 4.05% -6.56% -145.90% -23.26% -14.40%
NOPAT Q/Q Growth
70.16% 4.03% -16.30% -42.54% 76.95% 342.71% 18.50% 204.22% 18.24% -9.36% -30.25%
Net Income Q/Q Growth
59.57% 3.92% -7.68% -50.28% 58.68% 79.61% 46.83% 261.12% -139.48% -8.30% -28.13%
EPS Q/Q Growth
60.00% 4.32% -9.43% -50.09% 59.11% 80.00% 44.12% 222.62% -156.00% -14.58% -28.05%
Operating Cash Flow Q/Q Growth
-77.61% 21.49% 122.32% -91.94% 65.29% -0.37% 2.52% 17.32% -5.55% -1.69% -4.74%
Free Cash Flow Firm Q/Q Growth
100.98% 25.46% 0.90% 1,231.75% 119.14% -60.49% -7.89% 74.12% 70.63% 9.25% -12.03%
Invested Capital Q/Q Growth
0.72% 1.01% -1.24% -22.17% -10.58% 0.09% 2.65% 23.77% 1.48% 0.15% -1.51%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
37.15% 40.13% 37.05% 35.74% 37.72% 42.78% 41.54% 40.73% 42.77% 42.38% 39.95%
EBITDA Margin
3.48% -26.38% -2.38% -65.26% -3.21% 13.04% 15.70% 13.45% -0.16% 13.02% 8.46%
Operating Margin
-4.87% -36.23% -15.11% -76.65% -9.44% 4.97% 9.72% 9.33% 10.49% 9.34% 5.38%
EBIT Margin
-4.87% -36.23% -15.11% -76.65% -14.44% 3.24% 8.86% 9.33% -4.07% 9.34% 5.28%
Profit (Net Income) Margin
-6.70% -36.79% -10.80% -75.10% -18.78% -1.85% 4.46% 25.84% -4.56% 10.28% 5.33%
Tax Burden Percent
141.21% 102.37% 57.75% 93.84% 101.00% 99.14% 101.39% 327.43% 107.16% 107.09% 89.85%
Interest Burden Percent
97.48% 99.20% 123.82% 104.41% 128.74% -57.48% 49.67% 84.56% 104.37% 102.77% 112.36%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -1.39% -227.43% 0.00% -7.09% 10.15%
Return on Invested Capital (ROIC)
-4.86% -29.13% -9.68% -46.49% -6.28% 3.82% 13.50% 39.81% 8.22% 10.67% 4.51%
ROIC Less NNEP Spread (ROIC-NNEP)
-0.86% -18.77% -9.13% 827.08% -152.48% -104.29% -1,062.88% 299.11% 276.47% 6.67% 1.66%
Return on Net Nonoperating Assets (RNNOA)
0.46% 10.49% 2.52% -17.22% -13.10% -5.96% -7.34% -6.93% -13.08% -0.46% -0.23%
Return on Equity (ROE)
-4.40% -18.64% -7.16% -63.71% -19.39% -2.14% 6.16% 32.88% -4.86% 10.22% 4.27%
Cash Return on Invested Capital (CROIC)
0.22% -3.40% -112.83% 5.21% 4.08% 5.93% 5.76% 18.21% -7.24% 1.62% 1.86%
Operating Return on Assets (OROA)
-2.55% -14.57% -6.70% -36.32% -7.05% 1.72% 5.75% 5.95% -2.30% 5.40% 2.72%
Return on Assets (ROA)
-3.51% -14.80% -4.79% -35.58% -9.16% -0.98% 2.90% 16.47% -2.58% 5.94% 2.75%
Return on Common Equity (ROCE)
-4.40% -18.64% -7.16% -63.71% -19.39% -2.14% 6.16% 32.88% -4.86% 10.22% 4.27%
Return on Equity Simple (ROE_SIMPLE)
-4.47% -20.52% -6.12% -92.99% -21.02% -2.05% 5.95% 28.89% -4.52% 9.56% 0.00%
Net Operating Profit after Tax (NOPAT)
-16 -84 -50 -291 -28 16 58 197 49 72 32
NOPAT Margin
-3.41% -25.36% -10.58% -53.65% -6.61% 3.48% 9.86% 30.56% 7.35% 10.00% 4.83%
Net Nonoperating Expense Percent (NNEP)
-4.00% -10.36% -0.55% -873.57% 146.20% 108.11% 1,076.38% -259.30% -268.25% 4.00% 2.84%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 23.16% 5.17% 6.85% 2.89%
Cost of Revenue to Revenue
62.85% 59.87% 62.95% 64.26% 62.28% 57.22% 58.46% 59.27% 57.23% 57.62% 60.05%
SG&A Expenses to Revenue
18.91% 23.41% 21.07% 16.98% 19.02% 16.79% 14.49% 13.77% 13.92% 13.89% 14.89%
R&D to Revenue
16.46% 24.42% 17.24% 18.03% 21.59% 17.39% 15.20% 16.03% 16.93% 17.36% 18.01%
Operating Expenses to Revenue
42.02% 76.35% 52.16% 112.39% 47.16% 37.81% 31.81% 31.39% 32.28% 33.04% 34.58%
Earnings before Interest and Taxes (EBIT)
-23 -120 -72 -416 -61 15 52 60 -27 67 35
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
17 -88 -11 -354 -13 59 92 87 -1.07 93 56
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.18 1.99 0.85 0.81 1.92 2.11 3.29 1.65 2.60 1.97 1.94
Price to Tangible Book Value (P/TBV)
1.80 2.81 4.40 2.10 5.48 4.78 6.48 2.57 4.23 2.78 2.59
Price to Revenue (P/Rev)
1.76 3.57 1.51 0.65 1.71 1.90 2.47 1.48 2.62 2.12 2.59
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 55.22 5.72 0.00 20.64 48.59
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.81% 17.47% 0.00% 4.84% 2.06%
Enterprise Value to Invested Capital (EV/IC)
1.41 3.34 0.84 0.82 1.85 2.11 3.26 1.69 2.68 2.07 2.16
Enterprise Value to Revenue (EV/Rev)
0.96 2.53 1.40 0.70 1.84 1.90 2.47 1.44 2.58 2.03 2.34
Enterprise Value to EBITDA (EV/EBITDA)
27.56 0.00 0.00 0.00 0.00 14.56 15.75 10.67 0.00 15.56 27.68
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 58.57 27.90 15.38 0.00 21.70 44.37
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 54.59 25.09 4.70 35.08 20.26 48.47
Enterprise Value to Operating Cash Flow (EV/OCF)
29.01 0.00 18.99 0.00 0.00 20.04 21.30 8.55 27.85 22.77 22.38
Enterprise Value to Free Cash Flow (EV/FCFF)
628.66 0.00 0.00 11.66 42.96 35.11 58.83 10.27 0.00 133.35 117.60
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.33 0.66 0.80 0.79 0.52 0.48 0.41 0.36 0.26
Long-Term Debt to Equity
0.00 0.00 0.33 0.66 0.80 0.79 0.52 0.44 0.41 0.32 0.26
Financial Leverage
-0.54 -0.56 -0.28 -0.02 0.09 0.06 0.01 -0.02 -0.05 -0.07 -0.14
Leverage Ratio
1.25 1.26 1.50 1.79 2.12 2.19 2.12 2.00 1.89 1.72 1.56
Compound Leverage Factor
1.22 1.25 1.85 1.87 2.72 -1.26 1.06 1.69 1.97 1.77 1.75
Debt to Total Capital
0.21% 0.20% 24.70% 39.63% 44.48% 44.02% 34.40% 32.22% 29.02% 26.38% 20.33%
Short-Term Debt to Total Capital
0.05% 0.06% 0.00% 0.00% 0.00% 0.00% 0.00% 2.37% 0.00% 2.53% 0.00%
Long-Term Debt to Total Capital
0.17% 0.14% 24.70% 39.63% 44.48% 44.02% 34.40% 29.85% 29.02% 23.85% 20.33%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
99.79% 99.80% 75.30% 60.37% 55.52% 55.98% 65.60% 67.78% 70.98% 73.62% 79.67%
Debt to EBITDA
0.09 -0.01 -24.33 -0.81 -22.27 5.42 2.51 3.16 -257.68 2.96 4.02
Net Debt to EBITDA
-23.09 3.92 4.66 -0.07 -4.07 0.02 0.05 -0.33 28.91 -0.73 -2.92
Long-Term Debt to EBITDA
0.07 -0.01 -24.33 -0.81 -22.27 5.42 2.51 2.93 -257.68 2.67 4.02
Debt to NOPAT
-0.09 -0.01 -5.48 -0.99 -10.83 20.33 3.99 1.39 5.62 3.85 7.04
Net Debt to NOPAT
23.60 4.08 1.05 -0.09 -1.98 0.07 0.08 -0.14 -0.63 -0.95 -5.12
Long-Term Debt to NOPAT
-0.07 -0.01 -5.48 -0.99 -10.83 20.33 3.99 1.29 5.62 3.48 7.04
Altman Z-Score
3.76 4.50 1.07 -0.95 0.57 1.10 2.13 1.61 2.22 2.68 3.09
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
3.34 3.49 2.66 3.25 4.03 4.00 2.90 2.59 3.24 3.98 4.75
Quick Ratio
2.68 2.80 1.90 2.11 2.67 2.87 1.86 1.72 1.99 2.49 3.01
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
0.73 -9.81 -586 33 18 25 25 90 -43 11 13
Operating Cash Flow to CapEx
145.94% -1,212.20% 159.15% -298.23% -72.51% 0.00% 174.06% 440.92% 220.82% 396.86% 428.97%
Free Cash Flow to Firm to Interest Expense
1.57 -44.17 -30.12 1.52 0.81 0.99 0.86 7.85 -3.66 0.99 1.45
Operating Cash Flow to Interest Expense
34.03 -107.41 1.80 -1.75 -0.34 1.74 2.39 9.43 5.24 5.78 7.61
Operating Cash Flow Less CapEx to Interest Expense
10.71 -116.27 0.67 -2.34 -0.80 1.85 1.02 7.29 2.87 4.32 5.83
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.52 0.40 0.44 0.47 0.49 0.53 0.65 0.64 0.57 0.58 0.52
Accounts Receivable Turnover
8.70 6.17 6.06 6.15 5.66 5.27 5.09 4.81 4.97 5.49 4.75
Inventory Turnover
4.32 2.57 3.04 2.52 1.80 1.86 2.15 2.03 1.72 1.71 1.53
Fixed Asset Turnover
6.03 4.73 6.53 6.56 5.38 6.44 7.07 6.24 5.90 6.18 5.97
Accounts Payable Turnover
12.44 7.54 8.21 7.75 8.58 9.46 8.73 7.94 8.08 9.62 8.07
Days Sales Outstanding (DSO)
41.93 59.17 60.25 59.33 64.51 69.22 71.69 75.87 73.42 66.49 76.78
Days Inventory Outstanding (DIO)
84.58 142.00 120.26 144.89 202.22 195.92 169.53 180.01 212.73 213.88 238.84
Days Payable Outstanding (DPO)
29.33 48.41 44.44 47.11 42.55 38.58 41.80 45.99 45.19 37.93 45.23
Cash Conversion Cycle (CCC)
97.18 152.76 136.07 157.11 224.18 226.56 199.42 209.90 240.96 242.44 270.39
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
326 252 787 464 418 409 442 550 642 702 721
Invested Capital Turnover
1.43 1.15 0.92 0.87 0.95 1.10 1.37 1.30 1.12 1.07 0.93
Increase / (Decrease) in Invested Capital
-17 -74 536 -323 -46 -8.76 33 107 92 61 19
Enterprise Value (EV)
458 841 665 380 773 862 1,443 927 1,717 1,453 1,555
Market Capitalization
842 1,184 717 354 718 861 1,438 955 1,748 1,522 1,719
Book Value per Share
$17.45 $14.64 $17.39 $9.16 $7.66 $8.23 $8.67 $11.24 $11.94 $13.58 $14.72
Tangible Book Value per Share
$11.43 $10.37 $3.38 $3.52 $2.68 $3.63 $4.39 $7.23 $7.34 $9.63 $11.05
Total Capital
716 596 1,116 725 675 729 667 852 947 1,047 1,112
Total Debt
1.53 1.19 276 287 300 321 229 275 275 276 226
Total Long-Term Debt
1.19 0.83 276 287 300 321 229 254 275 250 226
Net Debt
-384 -343 -53 26 55 1.06 4.79 -28 -31 -68 -164
Capital Expenditures (CapEx)
11 1.97 22 13 10 -2.70 39 25 28 16 16
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-5.04 14 44 99 112 120 136 128 182 254 277
Debt-free Net Working Capital (DFNWC)
380 358 373 360 358 440 360 431 488 599 667
Net Working Capital (NWC)
380 358 373 360 358 440 360 411 488 572 667
Net Nonoperating Expense (NNE)
16 38 1.09 116 51 24 31 30 79 -1.98 -3.31
Net Nonoperating Obligations (NNO)
-389 -343 -53 26 44 1.06 4.79 -28 -31 -68 -164
Total Depreciation and Amortization (D&A)
40 33 61 62 47 44 40 27 26 26 21
Debt-free, Cash-free Net Working Capital to Revenue
-1.06% 4.26% 9.35% 18.22% 26.82% 26.47% 23.24% 19.84% 27.38% 35.44% 41.71%
Debt-free Net Working Capital to Revenue
79.71% 108.04% 78.38% 66.42% 85.29% 96.94% 61.75% 66.73% 73.26% 83.47% 100.45%
Net Working Capital to Revenue
79.64% 107.93% 78.38% 66.42% 85.29% 96.94% 61.75% 63.61% 73.26% 79.78% 100.45%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.80) ($3.11) ($1.01) ($8.63) ($1.66) ($0.17) $0.53 $3.35 ($0.56) $1.31 $0.60
Adjusted Weighted Average Basic Shares Outstanding
39.74M 39.34M 44.17M 47.15M 47.48M 48.36M 49.07M 49.91M 53.77M 56.43M 59.30M
Adjusted Diluted Earnings per Share
($0.80) ($3.11) ($1.01) ($8.63) ($1.66) ($0.17) $0.49 $2.71 ($0.56) $1.23 $0.59
Adjusted Weighted Average Diluted Shares Outstanding
39.74M 39.34M 44.17M 47.15M 47.48M 48.36M 53.64M 65.61M 53.77M 61.60M 60.59M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
39.97M 40.60M 48.16M 48.04M 49.00M 49.72M 50.65M 51.66M 56.37M 57.94M 60.39M
Normalized Net Operating Profit after Tax (NOPAT)
-13 -32 -29 -20 -20 17 40 42 49 67 40
Normalized NOPAT Margin
-2.70% -9.50% -6.05% -3.72% -4.87% 3.69% 6.81% 6.53% 7.35% 9.28% 6.03%
Pre Tax Income Margin
-4.75% -35.94% -18.71% -80.03% -18.59% -1.86% 4.40% 7.89% -4.25% 9.60% 5.93%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
-50.07 -541.27 -3.69 -19.31 -2.74 0.60 1.82 5.24 -2.31 6.06 3.84
NOPAT to Interest Expense
-35.05 -378.89 -2.59 -13.52 -1.25 0.64 2.03 17.15 4.16 6.49 3.51
EBIT Less CapEx to Interest Expense
-73.39 -550.13 -4.82 -19.90 -3.20 0.70 0.45 3.10 -4.68 4.61 2.06
NOPAT Less CapEx to Interest Expense
-58.37 -387.75 -3.72 -14.10 -1.72 0.75 0.66 15.02 1.79 5.04 1.74
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
-27.85% -10.94% -5.58% -2.81% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Veeco Instruments

This table displays calculated financial ratios and metrics derived from Veeco Instruments' official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding
- - - - - - - - - - 60,392,058.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 60,392,058.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - -0.01
Growth Metrics
- - - - - - - - - - -
Revenue Growth
3.17% 13.09% 13.67% 8.81% 4.20% 4.72% -4.12% -5.56% -10.24% -9.40% -5.35%
EBITDA Growth
19.03% 52.76% 76.27% 130.72% 7.15% -66.97% -32.37% -27.62% -48.92% -61.68% -86.51%
EBIT Growth
26.75% 80.58% 124.81% 120.05% 9.31% -83.96% -35.82% -29.93% -56.63% -135.19% -118.79%
NOPAT Growth
40.29% -85.17% 122.46% 52.78% -10.87% -38.40% -46.73% -21.45% -56.53% -107.17% -116.49%
Net Income Growth
63.38% -83.22% 150.02% 117.52% -10.67% -30.84% -45.33% -21.49% -51.73% -92.56% -102.71%
EPS Growth
55.56% -77.23% 117.65% 115.53% -14.29% -45.65% -45.95% -20.00% -52.78% -92.00% -105.00%
Operating Cash Flow Growth
-85.06% -10.95% -32.74% -24.62% 149.70% -3.73% 113.57% 6.94% -11.81% -12.19% -60.31%
Free Cash Flow Firm Growth
-3,914.07% -281.65% 55.99% 44.09% 71.02% 32.56% 46.18% 57.78% 54.63% 58.29% 35.46%
Invested Capital Growth
42.39% 16.76% 13.47% 14.22% 10.94% 9.48% 6.37% 6.03% 4.42% 2.68% 2.57%
Revenue Q/Q Growth
9.73% -1.94% 0.32% 0.80% 5.08% -1.45% -8.15% -0.71% -0.13% -0.52% -4.05%
EBITDA Q/Q Growth
137.37% 7.20% -6.75% -17.76% 30.32% -66.95% 90.91% -11.98% -8.02% -75.21% -32.78%
EBIT Q/Q Growth
126.69% 8.62% -8.84% -24.15% 45.53% -84.06% 264.73% -17.18% -9.93% -112.93% -94.73%
NOPAT Q/Q Growth
153.66% -10.97% -2.13% -30.87% 47.99% -38.47% -15.37% 1.94% -18.10% -110.15% -94.73%
Net Income Q/Q Growth
128.80% -11.95% 1.00% -31.62% 46.89% -31.83% -20.17% -1.79% -9.69% -89.49% -129.08%
EPS Q/Q Growth
126.09% 9.52% -19.57% -32.43% 44.00% -30.56% -20.00% 0.00% -15.00% -88.24% -150.00%
Operating Cash Flow Q/Q Growth
-37.11% 317.99% -68.25% -9.68% 108.33% 61.15% -29.57% -54.77% 71.79% 60.47% -68.17%
Free Cash Flow Firm Q/Q Growth
-29.67% 57.03% 17.87% -22.17% 32.80% -0.01% 34.46% 4.15% 27.79% 8.05% -1.41%
Invested Capital Q/Q Growth
5.35% 1.48% 3.79% 2.93% 2.33% 0.15% 0.84% 2.60% 0.77% -1.51% 0.73%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
43.34% 45.22% 43.22% 42.86% 42.86% 40.62% 40.93% 41.38% 40.81% 36.67% 35.26%
EBITDA Margin
16.21% 17.72% 16.47% 13.44% 16.67% 5.59% 11.62% 10.30% 9.49% 2.36% 1.66%
Operating Margin
12.55% 13.90% 12.63% 9.51% 13.17% 2.13% 8.46% 7.45% 6.36% -0.83% -1.68%
EBIT Margin
12.55% 13.90% 12.63% 9.51% 13.17% 2.13% 8.46% 7.05% 6.36% -0.83% -1.68%
Profit (Net Income) Margin
13.86% 12.44% 12.52% 8.50% 11.88% 8.22% 7.14% 7.06% 6.39% 0.68% -0.20%
Tax Burden Percent
109.17% 89.47% 96.06% 87.54% 89.02% 343.63% 79.73% 92.96% 89.23% -1,185.11% 21.85%
Interest Burden Percent
101.11% 100.00% 103.20% 102.09% 101.33% 112.27% 105.91% 107.72% 112.52% 6.89% 55.79%
Effective Tax Rate
-9.17% 10.53% 3.94% 12.46% 10.98% -243.63% 20.27% 7.04% 10.77% 0.00% 0.00%
Return on Invested Capital (ROIC)
16.46% 13.92% 13.32% 9.09% 12.47% 7.81% 6.97% 6.87% 5.40% -0.54% -1.07%
ROIC Less NNEP Spread (ROIC-NNEP)
10.71% 13.92% 6.75% 7.63% 11.46% 4.51% 5.91% 6.57% 4.15% -2.32% -2.25%
Return on Net Nonoperating Assets (RNNOA)
-0.09% -0.66% -0.11% -0.24% -0.47% -0.31% -0.49% -0.67% -0.48% 0.33% 0.35%
Return on Equity (ROE)
16.37% 13.26% 13.21% 8.84% 11.99% 7.50% 6.47% 6.20% 4.91% -0.21% -0.73%
Cash Return on Invested Capital (CROIC)
-27.28% -7.24% -3.43% -0.55% 1.50% 1.62% 2.81% 2.44% 2.10% 1.86% 0.12%
Operating Return on Assets (OROA)
7.23% 7.86% 7.23% 5.42% 7.41% 1.23% 4.78% 3.94% 3.38% -0.43% -0.84%
Return on Assets (ROA)
7.99% 7.03% 7.17% 4.84% 6.69% 4.75% 4.04% 3.94% 3.40% 0.35% -0.10%
Return on Common Equity (ROCE)
16.37% 13.26% 13.21% 8.84% 11.99% 7.50% 6.47% 6.20% 4.91% -0.21% -0.73%
Return on Equity Simple (ROE_SIMPLE)
11.93% 0.00% -2.51% 11.61% 10.77% 0.00% 7.86% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
24 22 21 15 22 13 11 11 9.42 -0.96 -1.86
NOPAT Margin
13.70% 12.44% 12.14% 8.32% 11.72% 7.32% 6.74% 6.92% 5.68% -0.58% -1.18%
Net Nonoperating Expense Percent (NNEP)
5.75% 0.00% 6.57% 1.45% 1.00% 3.30% 1.06% 0.29% 1.25% 1.78% 1.18%
Return On Investment Capital (ROIC_SIMPLE)
- 2.28% 2.20% - - 1.27% 1.06% 1.06% 0.85% -0.09% -0.17%
Cost of Revenue to Revenue
56.66% 54.78% 56.78% 57.14% 57.14% 59.38% 59.07% 58.62% 59.19% 63.33% 64.74%
SG&A Expenses to Revenue
12.86% 13.51% 14.16% 13.98% 13.69% 13.77% 14.96% 14.40% 16.44% 13.75% 16.43%
R&D to Revenue
16.25% 16.73% 16.99% 18.02% 17.43% 16.99% 17.04% 19.00% 17.48% 18.53% 18.87%
Operating Expenses to Revenue
30.79% 31.32% 30.59% 33.36% 29.69% 38.49% 32.47% 33.93% 34.45% 37.50% 36.94%
Earnings before Interest and Taxes (EBIT)
22 24 22 17 24 3.88 14 12 11 -1.37 -2.66
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
29 31 29 24 31 10 19 17 16 3.90 2.62
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.46 2.60 2.88 3.70 2.52 1.97 1.43 1.38 2.09 1.94 2.31
Price to Tangible Book Value (P/TBV)
4.13 4.23 4.60 5.75 3.82 2.78 1.98 1.87 2.80 2.59 3.08
Price to Revenue (P/Rev)
2.45 2.62 2.88 3.77 2.65 2.12 1.64 1.69 2.69 2.59 3.12
Price to Earnings (P/E)
20.59 0.00 0.00 31.87 23.40 20.64 18.23 19.55 37.18 48.59 88.45
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
4.86% 0.00% 0.00% 3.14% 4.27% 4.84% 5.48% 5.12% 2.69% 2.06% 1.13%
Enterprise Value to Invested Capital (EV/IC)
2.49 2.68 2.94 3.82 2.62 2.07 1.50 1.45 2.30 2.16 2.60
Enterprise Value to Revenue (EV/Rev)
2.43 2.58 2.85 3.73 2.59 2.03 1.49 1.51 2.48 2.34 2.88
Enterprise Value to EBITDA (EV/EBITDA)
18.41 0.00 18.07 23.36 16.10 15.56 12.61 13.49 26.73 27.68 47.16
Enterprise Value to EBIT (EV/EBIT)
26.57 0.00 23.85 30.70 21.04 21.70 17.94 19.28 41.20 44.37 99.88
Enterprise Value to NOPAT (EV/NOPAT)
37.96 35.08 34.06 32.00 23.20 20.26 17.17 18.01 36.68 48.47 99.02
Enterprise Value to Operating Cash Flow (EV/OCF)
24.07 27.85 34.31 48.13 28.29 22.77 14.24 14.06 23.13 22.38 32.87
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 184.06 133.35 54.86 61.21 112.22 117.60 2,268.70
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.43 0.41 0.40 0.39 0.37 0.36 0.31 0.26 0.26 0.26 0.26
Long-Term Debt to Equity
0.43 0.41 0.36 0.35 0.33 0.32 0.31 0.26 0.26 0.26 0.26
Financial Leverage
-0.01 -0.05 -0.02 -0.03 -0.04 -0.07 -0.08 -0.10 -0.12 -0.14 -0.15
Leverage Ratio
2.07 1.89 1.89 1.86 1.81 1.72 1.68 1.60 1.58 1.56 1.55
Compound Leverage Factor
2.09 1.89 1.95 1.89 1.84 1.93 1.77 1.72 1.78 0.11 0.87
Debt to Total Capital
29.88% 29.02% 28.58% 27.82% 26.98% 26.38% 23.54% 20.84% 20.49% 20.33% 20.38%
Short-Term Debt to Total Capital
0.00% 0.00% 2.74% 2.67% 2.59% 2.53% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
29.88% 29.02% 25.83% 25.15% 24.39% 23.85% 23.54% 20.84% 20.49% 20.33% 20.38%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
70.12% 70.98% 71.42% 72.18% 73.02% 73.62% 76.46% 79.16% 79.51% 79.67% 79.62%
Debt to EBITDA
3.22 -257.68 2.54 2.46 2.42 2.96 2.97 2.88 3.58 4.02 5.65
Net Debt to EBITDA
-0.14 28.91 -0.20 -0.26 -0.40 -0.73 -1.23 -1.66 -2.28 -2.92 -3.92
Long-Term Debt to EBITDA
3.22 -257.68 2.29 2.22 2.19 2.67 2.97 2.88 3.58 4.02 5.65
Debt to NOPAT
6.63 5.62 4.78 3.37 3.49 3.85 4.05 3.85 4.91 7.04 11.87
Net Debt to NOPAT
-0.30 -0.63 -0.38 -0.36 -0.57 -0.95 -1.68 -2.21 -3.12 -5.12 -8.24
Long-Term Debt to NOPAT
6.63 5.62 4.33 3.05 3.15 3.48 4.05 3.85 4.91 7.04 11.87
Altman Z-Score
1.97 2.36 2.68 3.60 2.76 2.52 2.18 2.40 3.36 3.00 3.25
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.69 3.24 3.05 3.52 3.54 3.98 4.44 5.10 5.36 4.75 4.23
Quick Ratio
1.64 1.99 1.87 2.14 2.25 2.49 2.80 3.21 3.42 3.01 2.69
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-164 -70 -58 -71 -47 -48 -31 -30 -22 -20 -20
Operating Cash Flow to CapEx
110.30% 275.59% 236.57% 286.32% 441.34% 548.08% 295.96% 251.52% 602.52% 761.80% 155.50%
Free Cash Flow to Firm to Interest Expense
-59.02 -22.97 -22.09 -25.55 -16.49 -17.09 -12.42 -13.03 -9.96 -9.11 -9.56
Operating Cash Flow to Interest Expense
2.54 9.62 3.57 3.06 6.11 10.21 7.98 3.95 7.18 11.46 3.78
Operating Cash Flow Less CapEx to Interest Expense
0.24 6.13 2.06 1.99 4.73 8.35 5.28 2.38 5.99 9.95 1.35
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.58 0.57 0.57 0.57 0.56 0.58 0.57 0.56 0.53 0.52 0.50
Accounts Receivable Turnover
3.98 4.97 4.93 4.97 4.50 5.49 4.92 5.10 4.39 4.75 4.09
Inventory Turnover
1.71 1.72 1.66 1.61 1.62 1.71 1.66 1.63 1.59 1.53 1.50
Fixed Asset Turnover
5.70 5.90 6.02 6.22 6.14 6.18 6.20 6.24 6.14 5.97 5.91
Accounts Payable Turnover
6.61 8.08 6.71 7.18 7.08 9.62 7.39 8.51 8.60 8.07 6.82
Days Sales Outstanding (DSO)
91.69 73.42 73.99 73.47 81.07 66.49 74.23 71.62 83.21 76.78 89.17
Days Inventory Outstanding (DIO)
212.93 212.73 220.05 226.02 225.26 213.88 219.73 224.41 229.16 238.84 243.11
Days Payable Outstanding (DPO)
55.24 45.19 54.42 50.81 51.52 37.93 49.42 42.91 42.45 45.23 53.49
Cash Conversion Cycle (CCC)
249.38 240.96 239.62 248.68 254.82 242.44 244.54 253.13 269.92 270.39 278.79
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
632 642 666 685 701 702 708 727 732 721 727
Invested Capital Turnover
1.20 1.12 1.10 1.09 1.06 1.07 1.03 0.99 0.95 0.93 0.91
Increase / (Decrease) in Invested Capital
188 92 79 85 69 61 42 41 31 19 18
Enterprise Value (EV)
1,572 1,717 1,960 2,616 1,836 1,453 1,060 1,055 1,687 1,555 1,888
Market Capitalization
1,584 1,748 1,982 2,646 1,881 1,522 1,163 1,184 1,831 1,719 2,045
Book Value per Share
$11.44 $11.94 $12.29 $12.62 $13.15 $13.58 $14.01 $14.69 $14.56 $14.72 $14.63
Tangible Book Value per Share
$6.81 $7.34 $7.70 $8.12 $8.68 $9.63 $10.16 $10.88 $10.88 $11.05 $10.99
Total Capital
919 947 963 991 1,022 1,047 1,062 1,082 1,102 1,112 1,110
Total Debt
275 275 275 276 276 276 250 225 226 226 226
Total Long-Term Debt
275 275 249 249 249 250 250 225 226 226 226
Net Debt
-12 -31 -22 -30 -45 -68 -104 -129 -144 -164 -157
Capital Expenditures (CapEx)
6.40 11 3.96 2.95 3.99 5.18 6.76 3.60 2.58 3.27 5.10
Debt-free, Cash-free Net Working Capital (DFCFNWC)
166 182 211 236 251 254 262 282 290 277 283
Debt-free Net Working Capital (DFNWC)
453 488 508 541 572 599 616 637 659 667 667
Net Working Capital (NWC)
453 488 482 514 546 572 616 637 659 667 667
Net Nonoperating Expense (NNE)
-0.27 0.00 -0.68 -0.31 -0.29 -1.64 -0.67 -0.23 -1.18 -2.07 -1.54
Net Nonoperating Obligations (NNO)
-12 -31 -22 -30 -45 -68 -104 -129 -144 -164 -157
Total Depreciation and Amortization (D&A)
6.49 6.64 6.70 6.92 6.48 6.30 5.29 5.39 5.19 5.27 5.28
Debt-free, Cash-free Net Working Capital to Revenue
25.70% 27.38% 30.66% 33.57% 35.43% 35.44% 36.96% 40.23% 42.53% 41.71% 43.25%
Debt-free Net Working Capital to Revenue
70.09% 73.26% 73.89% 77.06% 80.71% 83.47% 86.74% 90.91% 96.73% 100.45% 101.74%
Net Working Capital to Revenue
70.09% 73.26% 70.05% 73.29% 76.97% 79.78% 86.74% 90.91% 96.73% 100.45% 101.74%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.44 $0.44 $0.39 $0.27 $0.39 $0.26 $0.21 $0.20 $0.18 $0.01 ($0.01)
Adjusted Weighted Average Basic Shares Outstanding
55.35M 53.77M 55.97M 56.28M 56.41M 56.43M 57.75M 59.08M 60.08M 59.30M 60.41M
Adjusted Diluted Earnings per Share
$0.42 $0.46 $0.37 $0.25 $0.36 $0.25 $0.20 $0.20 $0.17 $0.02 ($0.01)
Adjusted Weighted Average Diluted Shares Outstanding
59.64M 53.77M 60.76M 62.54M 62.65M 61.60M 60.23M 60.24M 60.95M 60.59M 60.41M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
56.34M 56.37M 56.64M 56.78M 56.78M 57.94M 58.29M 60.16M 60.16M 60.39M 61.03M
Normalized Net Operating Profit after Tax (NOPAT)
16 22 21 15 22 2.72 11 11 9.42 -0.96 -0.45
Normalized NOPAT Margin
8.79% 12.44% 12.14% 8.32% 11.72% 1.49% 6.74% 6.92% 5.68% -0.58% -0.29%
Pre Tax Income Margin
12.69% 13.90% 13.04% 9.71% 13.34% 2.39% 8.96% 7.60% 7.16% -0.06% -0.94%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
8.02 7.89 8.42 6.05 8.45 1.40 5.65 5.12 4.88 -0.63 -1.27
NOPAT to Interest Expense
8.75 7.06 8.09 5.29 7.52 4.80 4.50 5.02 4.35 -0.44 -0.89
EBIT Less CapEx to Interest Expense
5.71 4.40 6.91 4.98 7.06 -0.47 2.95 3.55 3.69 -2.13 -3.69
NOPAT Less CapEx to Interest Expense
6.45 3.57 6.57 4.22 6.13 2.93 1.81 3.45 3.16 -1.94 -3.31
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Here’s a concise four-year trend snapshot for Veeco Instruments (VECO) using the latest quarterly data. The bullets highlight the 10 most material points that could impact the stock’s risk/reward profile for retail investors.

  • Net income available to common shareholders in Q4 2025: $1,114,000, a positive quarterly bottom-line result.
  • Operating cash flow in Q4 2025: $24,926,000, showing solid cash generation from core operations.
  • Estimated free cash flow in Q4 2025: about $21,654,000 (OCF of $24,926,000 less capex of $3,272,000), reflecting cash that could be returned to shareholders or reinvested.
  • Debt reduction in 2025 (long-term debt): declined from about $249.4M in Q1 2025 to $225.7M by Q3 2025 (roughly a $23.7M reduction), improving leverage metrics.
  • Liquidity position: cash & equivalents around $193.2M and total current assets near $810.3M (as of Q3 2025), indicating solid liquidity headroom.
  • Equity base held strong in 2025: total equity around $875.97M in Q3 2025, with ongoing equity activity (issuance noted in later cash flow) supporting a robust capital base.
  • Revenue stability in 2025: quarterly operating revenue hovered in the mid-$160M range (Q1–Q4 2025: $167.29M, $166.10M, $165.88M, $165.02M respectively), suggesting a stable top line.
  • Gross margin range: gross margin generally in the mid-30s to low-40s percent across 2025 quarters, indicating stable but not expanding profitability (e.g., Q4 2025 gross margin around 36.7%).
  • Earnings per share (EPS) volatility in 2025: diluted EPS ranged from around $0.17–$0.18 in some quarters to about $0.02 in Q4 2025, reflecting quarterly effects and potential one-offs.
  • Q4 2025 net cash from financing and overall cash drift: net change in cash for Q4 2025 was -$29,756,000, driven by sizable investing activity and outflows despite positive operating cash flow in the quarter.
05/16/26 07:10 PM ETAI Generated. May Contain Errors.

Veeco Instruments Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Veeco Instruments' financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Veeco Instruments' net income appears to be on a downward trend, with a most recent value of $35.39 million in 2025, falling from -$31.98 million in 2015. The previous period was $73.71 million in 2024. See Veeco Instruments' forecast for analyst expectations on what's next for the company.

Veeco Instruments' total operating income in 2025 was $35.71 million, based on the following breakdown:
  • Total Gross Profit: $265.41 million
  • Total Operating Expenses: $229.70 million

Over the last 10 years, Veeco Instruments' total revenue changed from $477.04 million in 2015 to $664.29 million in 2025, a change of 39.3%.

Veeco Instruments' total liabilities were at $440.29 million at the end of 2025, a 8.4% decrease from 2024, and a 149.9% increase since 2015.

In the past 10 years, Veeco Instruments' cash and equivalents has ranged from $119.75 million in 2021 to $279.74 million in 2017, and is currently $163.47 million as of their latest financial filing in 2025.

Over the last 10 years, Veeco Instruments' book value per share changed from 17.45 in 2015 to 14.72 in 2025, a change of -15.7%.



Financial statements for NASDAQ:VECO last updated on 5/7/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners